retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Early trial data for retatrutide

4 One study showed these tend to be mild to moderate, occurring primarily when increasing dosage levels

Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, et al

PMID 29662388

The pineal gland helps regulate melatonin, a hormone that supports sleep timing and circadian rhythm (the bodys 24-hour clock)

The apparent stimulation of EGR-1 expression by BPC-157 may suggest a hypothetical mechanism by which it may possibly improve wound healing

Glossary CKD Chronic kidney disease CVD Cardiovascular disease FDA Food and Drug Administration GLP-1 Glucagon-like peptide-1 GLP-1s Glucagon-like peptide-1 receptor agonists HF Heart failure MASH Metabolic dysfunction-associated steatohepatitis OA Osteoarthritis OSA Obstructive sleep apnea PAD Peripheral arterial disease SC Subcutaneous T2DM Type 2 diabetes mellitus U.S